American Century Companies’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-63,347
| Closed | -$2.1M | – | 2723 |
|
|
2022
Q4 | $2.1M | Buy |
63,347
+1,145
| +2% | +$36.9K | ﹤0.01% | 1530 |
|
|
2022
Q3 | $1.96M | Sell |
62,202
-317
| -0.5% | -$10.3K | ﹤0.01% | 1454 |
|
|
2022
Q2 | $1.9M | Buy |
62,519
+7,875
| +14% | +$213K | ﹤0.01% | 1445 |
|
|
2022
Q1 | $1.42M | Buy |
54,644
+5,463
| +11% | +$130K | ﹤0.01% | 1542 |
|
|
2021
Q4 | $1M | Buy |
49,181
+5,127
| +12% | +$98.3K | ﹤0.01% | 1645 |
|
|
2021
Q3 | $848K | Buy |
44,054
+4,950
| +13% | +$98.7K | ﹤0.01% | 1667 |
|
|
2021
Q2 | $867K | Buy |
39,104
+8,727
| +29% | +$185K | ﹤0.01% | 1610 |
|
|
2021
Q1 | $797K | Buy |
30,377
+7,866
| +35% | +$187K | ﹤0.01% | 1538 |
|
|
2020
Q4 | $421K | Buy |
+22,511
| New | +$420K | ﹤0.01% | 1616 |
|
|
2020
Q3 | – | Sell |
-14,736
| Closed | -$343K | – | 1880 |
|
|
2020
Q2 | $343K | Buy |
+14,736
| New | +$214K | ﹤0.01% | 1406 |
|
|
2019
Q3 | – | Sell |
-42,348
| Closed | -$503K | – | 1349 |
|
|
2019
Q2 | $503K | Sell |
42,348
-59,794
| -59% | -$720K | ﹤0.01% | 1140 |
|
|
2019
Q1 | $1.8M | Sell |
102,142
-4,539
| -4% | -$75.5K | ﹤0.01% | 1002 |
|
|
2018
Q4 | $1.85M | Sell |
106,681
-2,698
| -2% | -$46K | ﹤0.01% | 987 |
|
|
2018
Q3 | $1.63M | Sell |
109,379
-2,888
| -3% | -$44.8K | ﹤0.01% | 1053 |
|
|
2018
Q2 | $1.78M | Sell |
112,267
-18,818
| -14% | -$281K | ﹤0.01% | 1035 |
|
|
2018
Q1 | $1.86M | Sell |
131,085
-6,221
| -5% | -$92.1K | ﹤0.01% | 1011 |
|
|
2017
Q4 | $1.92M | Buy |
+137,306
| New | +$2.01M | ﹤0.01% | 1017 |
|
|
2016
Q1 | – | Sell |
-44,209
| Closed | -$907K | – | 1392 |
|
|
2015
Q4 | $907K | Buy |
44,209
+29,484
| +200% | +$565K | ﹤0.01% | 1125 |
|
|
2015
Q3 | $248K | Buy |
+14,725
| New | +$269K | ﹤0.01% | 1298 |
|
|
2014
Q3 | – | Sell |
-39,277
| Closed | -$811K | – | 1518 |
|
|
2014
Q2 | $811K | Buy |
39,277
+2,429
| +7% | +$49.9K | ﹤0.01% | 1256 |
|
|
2014
Q1 | $803K | Sell |
36,848
-2,780
| -7% | -$63.7K | ﹤0.01% | 1266 |
|
|
2013
Q4 | $1.05M | Hold |
39,628
| – | – | ﹤0.01% | 1229 |
|
|
2013
Q3 | $937K | Buy |
39,628
+2,460
| +7% | +$57.4K | ﹤0.01% | 1248 |
|
|
2013
Q2 | $799K | Buy |
+37,168
| New | +$802K | ﹤0.01% | 1240 |
|
Other funds holding VIVO
American Century Companies's VIVO Position: Q1 2023 in Review
American Century Companies sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 63,347 shares — an estimated $2.1M sold.
American Century Companies first reported a position in VIVO in Q2 2013 and held it in 24 quarters. The position peaked at $2.1M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- American Century Companies reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- American Century Companies sold 63,347 Meridian Bioscience Inc shares in Q1 2023, an estimated $2.1M.
- American Century Companies first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 24 quarters.
- American Century Companies's Meridian Bioscience Inc position peaked at $2.1M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on American Century Companies's 13F filing for Q1 2023, filed 11 May 2023.